Egenesis Stock

egenesisbio.comHealthcareFounded: 2015Funding to Date: $264.72MM

eGenesis’s goal is to transform the field of transplantation by offering safe and effective organs, tissues, and cells to patients in need by harnessing cutting-edge gene editing technologies to address the key issues that have impeded xenotransplantation to date.

Register for Details

For more details on financing and valuation for Egenesis, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Egenesis.

Register Today

Other companies like Egenesis in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
 
 
Sector
Last Round Est. Valuation
$317.32MM
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$1.59B
Sector
Last Round Est. Valuation
$4.26B
Sector